Tag Archives: nanomedicine

Core-Shell Nanomedicine for Targeting Multiple Targets in Cancer

Nano Medicine

The Amrita Center for Nanosciences and Molecular Medicine has developed a novel core-shellnanomedicine that can simultaneously target two critical cancer mechanisms in drug resistant blood cancer. Chronic myeloid leukemia (CML) is a type of blood cancer caused by a protein known as BCR-ABL, a protein not found in healthy individuals. Existing drugs, such as Imatinib and Dasatinib, can prevent the development of the BCR-ABL ... Read More »